​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 81.49% institutional investors, 11.75% insiders, and 6.77% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.47% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics81.49%11.75%6.77%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock16.54M16.09%$537.36M
Blackrock funding, inc. /de15.68M15.17%$789.98M
Vanguard group10.12M9.79%$509.73M
Ingalls & snyder8.10M7.84%$408.15M
Renaissance6.20M6.00%$312.35M
Parallel advisors3.83M3.70%$192.98M
State street3.55M3.43%$178.80M
Dimensional fund advisors lp2.08M2.01%$104.74M
Geode capital management2.07M2.00%$104.24M
Arrowstreet capital, limited partnership1.64M1.59%$82.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ingalls & snyder8.10M16.01%$408.15M
Tanaka capital management111.55K12.85%$5.62M
Parallel advisors3.83M4.34%$192.98M
Birchview capital, lp74.00K3.04%$3.73M
S&t bank/pa156.69K2.52%$7.90M
Synergy asset management462.41K1.73%$22.37M
Fas wealth partners309.21K1.31%$15.58M
Intrinsic edge capital management186.15K1.14%$9.38M
Lisanti capital growth77.67K0.94%$3.91M
Burney co/473.82K0.84%$23.88M

Top Buyers

HolderShares% AssetsChange
Norges bank834.59K0.01%834.59K
Qube research412.26K0.03%353.73K
Braun stacey associates296.39K0.56%296.39K
Millennium management508.36K0.01%269.13K
Synergy asset management462.41K1.73%262.50K

Top Sellers

HolderShares% AssetsChange
Novo---2.41M
Ikarian capital---994.50K
Boston trust walden899.06K0.32%-614.91K
Kynam capital management, lp---585.90K
Bank of america corp /de/174.85K0.00%-498.50K

New Positions

HolderShares% AssetsChangeValue
Norges bank834.59K0.01%834.59K$42.06M
Braun stacey associates296.39K0.56%296.39K$14.94M
Raymond james financial239.80K0.00%239.80K$12.08M
Van eck associates88.97K0.01%88.97K$4.48M
Tudor investment corp et al53.17K0.01%53.17K$2.68M

Sold Out

HolderChange
Claris advisors, llc / mo /-6.00
Mendota financial group-7.00
Nelson, van denburg & campbell wealth management group-16.00
Innealta capital-33.00
Northwestern mutual wealth management-72.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202438312.98%84,233,711-3.36%811.15%20015.61%12014.29%
Sep 30, 202433511.67%87,110,973-2.41%841.12%17420.00%101-11.40%
Jun 30, 2024295-4.53%89,230,600-3.86%861.06%141-16.07%11328.41%
Mar 31, 20243097.29%92,808,6509.52%901.35%16819.15%88-7.37%
Dec 31, 202328812.50%84,743,8882.02%811.23%14115.57%953.26%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.77M5.47%3.30K
Vanguard US Total Market Shares ETF2.83M2.68%213.93K
Vanguard Total Stock Mkt Idx Inv2.81M2.67%1.79K
Vanguard Small Cap Index2.27M2.16%1.85K
iShares Russell 2000 ETF2.13M2.02%-18.43K
Vanguard Institutional Extnd Mkt Idx Tr1.42M1.34%1.97K
Vanguard Small Cap Growth Index Inv1.28M1.21%-7.50K
iShares S&P Small-Cap 600 Growth ETF849.71K0.81%-
SPDR® Portfolio S&P 600™ Sm Cap ETF808.00K0.77%1.21K
Fidelity Small Cap Index797.86K0.76%-14.94K

Recent Insider Transactions

DateNameRoleActivityValue
Apr 10, 2025Swisher Daniel N JR-Sell$154.48K
Apr 01, 2025Maduck Sean See RemarksSell$67.58K
Mar 31, 2025Maduck Sean See RemarksSell$7.95M
Mar 31, 2025Maduck Sean See RemarksSell$1.53M
Mar 31, 2025Maduck Sean See RemarksSell$571.08K

Insider Transactions Trends

DateBuySell
2025 Q2-4
2025 Q1-22
2024 Q4-7
2024 Q3-8
2024 Q2-12

CORT Ownership FAQ

Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 81.49%, followed by 11.75% insiders and 6.76% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 68.48%, which Corcept Therapeutics exceeds.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Blackrock funding, inc. /de (15.68M shares, 15.17%), and Vanguard group (10.12M shares, 9.79%). Together, they hold 41.04% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Ingalls & snyder is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.01% of its assets in 8.1M Corcept Therapeutics shares, valued at 408.15M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.47% of its total shares outstanding invested in 5.77M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools